Usual and unusual pitfalls of 18F-FDG-PET/CT in lymphoma after treatment: a pictorial review - Université Claude Bernard Lyon 1 Accéder directement au contenu
Article Dans Une Revue Nuclear Medicine Communications Année : 2017

Usual and unusual pitfalls of 18F-FDG-PET/CT in lymphoma after treatment: a pictorial review

Résumé

Fluorine-18-fluorodeoxyglucose (F-FDG) PET/computed tomography (CT) is now a standard of care in initial staging and treatment evaluation of lymphomas. It is also used in the interim evaluation in diffuse large B cell lymphoma and Hodgkin lymphoma. However, several pitfalls may occur during or after treatment, because of the nonspecificity of F-FDG for lymphoma disease and treatment as immunotherapy, thus possibly induces misinterpretation and wrong treatment decision. The aim of this pictorial review is to provide an illustrated tutorial of the most frequent pitfalls found on F-FDG-PET/CT during or after treatment.

Domaines

Cancer
Fichier principal
Vignette du fichier
dubreuil2017.pdf (664.98 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-01568598 , version 1 (11-12-2018)

Identifiants

Citer

Julien Dubreuil, Gilles Salles, Juliette Bozzetto, Jeremie Tordo, Loïc Djaïleb, et al.. Usual and unusual pitfalls of 18F-FDG-PET/CT in lymphoma after treatment: a pictorial review. Nuclear Medicine Communications, 2017, 38 (7), pp.563-576. ⟨10.1097/MNM.0000000000000697⟩. ⟨hal-01568598⟩
427 Consultations
1969 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More